Ryvu Therapeutics SA (RVU) — Tangible Net Worth Ratio
Ryvu Therapeutics SA (RVU) has a Tangible Net Worth Ratio of 88.8% as of December 2025. This metric is calculated by deducting intangible assets (zł6.04 Million) from net assets (zł53.83 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of Ryvu Therapeutics SA to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Ryvu Therapeutics SA Tangible Net Worth Ratio (2010–2025)
This chart shows how Ryvu Therapeutics SA's Tangible Net Worth Ratio has changed across 16 annual periods from 2010 to 2025. As of December 2025, the ratio stands at 88.8%, reflecting net assets of zł53.83 Million with intangible assets of zł6.04 Million PLN. See Ryvu Therapeutics SA (RVU) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Ryvu Therapeutics SA (2010–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Ryvu Therapeutics SA from 2010 to 2025, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Ryvu Therapeutics SA (RVU) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (PLN) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.8% | zł53.83 Million | zł6.04 Million | zł224.44 Million | ▼ -5.6 pp |
| 2024 | 94.4% | zł143.88 Million | zł8.12 Million | zł378.78 Million | ▼ -3.2 pp |
| 2023 | 97.6% | zł259.59 Million | zł6.34 Million | zł403.20 Million | ▼ -1.2 pp |
| 2022 | 98.8% | zł343.39 Million | zł4.28 Million | zł474.98 Million | ▲ +0.6 pp |
| 2021 | 98.2% | zł169.42 Million | zł3.04 Million | zł228.81 Million | ▼ -0.8 pp |
| 2020 | 99.0% | zł223.72 Million | zł2.32 Million | zł295.64 Million | ▲ +1.4 pp |
| 2019 | 97.6% | zł119.76 Million | zł2.92 Million | zł182.89 Million | ▼ -1.2 pp |
| 2018 | 98.8% | zł194.86 Million | zł2.40 Million | zł255.70 Million | ▲ +2.5 pp |
| 2017 | 96.3% | zł64.00 Million | zł2.36 Million | zł103.57 Million | ▲ +7.7 pp |
| 2016 | 88.6% | zł55.71 Million | zł6.36 Million | zł89.12 Million | ▼ -7.2 pp |
| 2015 | 95.7% | zł46.88 Million | zł1.99 Million | zł65.24 Million | ▼ -3.7 pp |
| 2014 | 99.5% | zł9.25 Million | zł50.45K | zł26.80 Million | ▼ -0.5 pp |
| 2013 | 100.0% | zł3.13 Million | zł1.05K | zł17.98 Million | ▲ +0.1 pp |
| 2012 | 99.9% | zł5.53 Million | zł4.88K | zł15.35 Million | ▲ +19.7 pp |
| 2011 | 80.2% | zł11.46 Million | zł2.27 Million | zł17.50 Million | ▼ -19.8 pp |
| 2010 | 100.0% | zł1.50 Million | zł0.00 | zł10.27 Million | — |